Showing 8881-8890 of 20397 results for "".
- Reframing Muscle Preservation in Type 2 Diabetes: Beyond Glycemic Controlhttps://reachmd.com/news/reframing-muscle-preservation-in-type-2-diabetes-beyond-glycemic-control/2475636/Muscle mass reduction is a commonly observed complication in type 2 diabetes, impacting patient health and quality of life. Recent discoveries have unveiled molecular links and metabolic dysfunctions crucial for novel intervention strategies.
- Emerging Roles of Coffee Polyphenols in Type 2 Diabetes Managementhttps://reachmd.com/news/emerging-roles-of-coffee-polyphenols-in-type-2-diabetes-management/2475449/Amidst the search for holistic strategies, emerging data are revealing how coffee’s polyphenolic compounds could enhance glycemic stability and attenuate inflammation in type 2 diabetes management. As primary care physicians and endocr
- Emerging Biomarkers in Type 2 Diabetes: A New Horizon in Early Diagnosishttps://reachmd.com/news/emerging-biomarkers-in-type-2-diabetes-a-new-horizon-in-early-diagnosis/2474920/Recent research suggests that emerging molecular signatures and neuroproteins may improve type 2 diabetes care by offering tools that could help diagnose insulin resistance earlier and assess cognitive decline risk, using markers linked with
- Mitigating CGM Alarm Fatigue in Pediatric Type 1 Diabeteshttps://reachmd.com/news/cgm-alarm-fatigue-pediatric-type-1-diabetes/2484804/Continuous glucose monitoring (CGM) alarm fatigue is emerging as a leading barrier to sustained device use for children with type 1 diabetes and their caregivers. The literature document
- UK Study Advocates Early Screening for Childhood Type 1 Diabetes: Clinical and Program Implicationshttps://reachmd.com/news/uk-study-advocates-early-screening-for-childhood-type-1-diabetes-clinical-and-program-implications/2485410/The ELSA study shows that population screening for childhood type 1 diabetes detects presymptomatic disease a
- Puberty Onset Shifts Forward in Children with Type 1 Diabeteshttps://reachmd.com/news/puberty-onset-shifts-forward-in-children-with-type-1-diabetes/2452636/Puberty in both girls and boys with type 1 diabetes has shifted forward over the last two decades, according to research presented at the 61st Annual European Society for Paediatric Endocrinology Meeting in The Hague. Additionally, longer duration of diabetes, bigger waistlines, and
- Lithocholic Acid: A Translational Pathway to Metabolic Health in Type 2 Diabeteshttps://reachmd.com/news/lithocholic-acid-a-translational-pathway-to-metabolic-health-in-type-2-diabetes/2485401/Lithocholic acid (LCA) shows preclinical benefit for glycemic control in a diet‑plus‑streptozotocin mouse model of type 2 diabetes. C57BL/6 mice given daily oral gavage of LCA (50 mg/kg) for four
- Emerging Roles of SGLT2 Inhibitors and GLP-1 RAs in Managing Gout and Type 2 Diabeteshttps://reachmd.com/news/emerging-roles-of-sglt2-inhibitors-and-glp-1-ras-in-managing-gout-and-type-2-diabetes/2475471/Emerging Roles of Sodium‐Glucose Co-Transporter‐2 (SGLT2) Inhibitors and Glucagon‐Like Peptide‐1 Receptor Agonists (GLP-1 RAs) in Managing Gout and Type 2 Diabetes As clinicians face the dual challenge of managing type
- Maternal Type 2 Diabetes Not Linked to Reduced AD Risk in Children: Studyhttps://reachmd.com/news/maternal-type-2-diabetes-not-linked-to-reduced-ad-risk-in-children-study/2487400/New research suggests maternal type 2 diabetes mellitus (T2DM) does not independently influence the risk of atopic dermatitis (AD) in children. Researchers for a retrospective cohort study analyzed electronic medical and birth records from Clalit Health Services in Israel (n = 314,224 moth
- Real-Time CGM Lowers HbA1c vs SMBG in Type 2 Diabeteshttps://reachmd.com/news/real-time-cgm-lowers-hba1c-vs-smbg-in-type-2-diabetes/2487104/Key Takeaways Lower HbA1c was observed with CGM than with SMBG at both prespecified assessments. The open-label multicentre randomized trial enrolled adults with type 2 diabetes receiving basal insulin plus SGLT2 inhibitors, GLP-1 receptor agonists, or